Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

• Agrawal, A. & Lynskey, M.T. (2009). Correlates of later-onset cannabis use in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence 105, 71-75.
• Alexander, A., Smith, P.F. & Rosengren, R.J. (2009). Cannabinoids in the treatment of cancer. Cancer Letters 285, 6-12.
• Booker, L., Naidu, P.S., Razdan, R.K., Mahadevan, A., & Lichtman, A.H. (2009). Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception. Drug and Alcohol Dependence 105, 42-47.
• Borrelli, F., Aviello, G., Romano, B., Orlando, P., Capasso, R., Maiello, F., Guadagno, F., Petrosino, S., Capasso, F., Di Marzo, V., & Izzo, A.A. (2009). Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant cannabis sativa, is protective in a murine model of colitis. Journal of Molecular Medicine (Berlin, Germany) 87, 1111-1121.
• Bouchard, M., Alain, M. & Nguyen, H. (2009). Convenient labour: The prevalence and nature of youth involvement in the cannabis cultivation industry. The International Journal on Drug Policy 20, 467-474.
• Boucher, A., Vilette, P., Crassard, N., Bernard, N., & Descotes, J. (2009). Urinary toxicological screening: Analytical interference between niflumic acid and cannabis. Archives de Pédiatrie 16, 1457-1460.
• Compton, M.T., Kelley, M.E., Ramsay, C.E., Pringle, M., Goulding, S.M., Esterberg, M.L., Stewart, T., & Walker, E.F. (2009). Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. The American Journal of Psychiatry 166, 1251-1257.
• Fernandez-Espejo, E., Viveros, M.P., Núñez, L., Ellenbroek, B.A., & Rodriguez de Fonseca, F. (2009). Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) 206, 531-549.
• Gunasekaran, N., Long, L.E., Dawson, B.L., Hansen, G.H., Richardson, D.P., Li, K.M., Arnold, J.C., & McGregor, I.S. (2009). Reintoxication: The release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. British Journal of Pharmacology 158, 1330-1337.
• Hall, W. (2009). The adverse health effects of cannabis use: What are they, and what are their implications for policy? The International Journal on Drug Policy 20, 458-466.
• Hallinan, R., Crettol, S., Agho, K., Attia, J., Besson, J., Croquette-Krokar, M., Hämmig, R., Déglon, J.J., Byrne, A., Ray, J., Somogyi, A.A., & Eap, C.B. (2009). Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: A transnational study. European Journal of Clinical Pharmacology 65, 1113-1120.
• Hickman, M., Vickerman, P., Macleod, J., Lewis, G., Zammit, S., Kirkbride, J., & Jones, P. (2009). If cannabis caused schizophrenia – how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction 104, 1856-1861.
• Huang, P., Liu-Chen, L.Y., Unterwald, E.M., & Cowan, A. (2009). Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice. Neuroscience Letters 465, 66-70.
• Koethe, D., Hoyer, C. & Leweke, F.M. (2009). The endocannabinoid system as a target for modelling psychosis. Psychopharmacology (Berlin) 206, 551-561.
• Lowe, R.H., Abraham, T.T., Darwin, W.D., Herning, R., Cadet, J.L., & Huestis, M.A. (2009). Extended urinary delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug and Alcohol Dependence 105, 24-32.
• Pomahacova, B., Van der Kooy, F. & Verpoorte, R. (2009). Cannabis smoke condensate III: The cannabinoid content of vaporised cannabis sativa. Inhalation Toxicology 21, 1108 -1112.
• Roser, P., Della, B., Norra, C., Juckel, G., & Uhl, I. (2009). No association between chronic cannabis use and loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission. Neuroscience Letters 465, 113-117.
• Scherrer, J.F., Grant, J.D., Duncan, A.E., Sartor, C.E., Haber, J.R., Jacob, T., & Bucholz, K.K. (2009). Subjective effects to cannabis are associated with use, abuse and dependence after adjusting for genetic and environmental influences. Drug and Alcohol Dependence 105, 76-82.
• Westfall, R.E., Janssen, P.A., Lucas, P., & Capler, R. (2009). Reprint of: Survey of medicinal cannabis use among childbearing women: Patterns of its use in pregnancy and retroactive self-assessment of its efficacy against ‘morning sickness’. Complementary Therapies in Clinical Practice 15, 242-246.